Koa Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Koa Wealth Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-8,834	Closed	-$796K	–	53
2024 Q4	$796K	Sell	8,834 -389	-4%	-$37.7K	0.65%	35
2024 Q3	$911K	Sell	9,223 -861	-9%	-$84.6K	0.7%	35
2024 Q2	$935K	Buy	10,084 +232	+2%	+$20.8K	0.79%	32
2024 Q1	$935K	Buy	9,852 +477	+5%	+$44.3K	0.84%	32
2023 Q4	$837K	Buy	+9,375	New	+$696K	0.83%	30

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Koa Wealth Management's XBI Position: Q1 2025 in Review

Koa Wealth Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2025, closing a stake of 8,834 shares — an estimated $796K sold.

Koa Wealth Management first reported a position in XBI in Q4 2023 and held it in 5 quarters. The position peaked at $935K in Q2 2024. 685 funds tracked by Wall St. Rank hold XBI as of Q1 2025.

Koa Wealth Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2025 after selling out during the quarter.
Koa Wealth Management sold 8,834 State Street SPDR S&P Biotech ETF shares in Q1 2025, an estimated $796K.
Koa Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2023 and held it in 5 quarters.
Koa Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $935K in Q2 2024.
685 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2025.

Based on Koa Wealth Management's 13F filing for Q1 2025, filed 12 May 2025.